John Neis, Director at Cellectar Biosciences, Inc. (CLRB), sold 198 shares at $3.70 ($733) on 2025-12-12, disclosed to the SEC on 2025-12-16.
Open-market sale of $733 CLRB by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CLRB | BUY | 2016-04-21 | $995K | — | Filing → |
| CLRB | BUY | 2014-08-22 | $1.0M | — | Filing → |
| TTPY | SELL | 2007-10-18 | $14.1M | — | Filing → |